-
1 Comment
Medgold Resources Corp is currently in a long term downtrend where the price is trading 21.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.0.
Medgold Resources Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 128.6% to $-483K since the same quarter in the previous year.
Finally, its free cash flow fell by 446.1% to $-551K since the same quarter in the previous year.
Based on the above factors, Medgold Resources Corp gets an overall score of 1/5.
Sector | Basic Materials |
---|---|
Industry | Other Precious Metals & Mining |
Exchange | V |
CurrencyCode | CAD |
ISIN | CA58436R2019 |
Target Price | None |
---|---|
PE Ratio | None |
Dividend Yield | 0.0% |
Beta | 0.61 |
Market Cap | 42K |
Medgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of precious metal properties in Europe. The company explores for gold, silver, copper, lead, and zinc deposits. It holds a 100% interest in the Tlamino project comprising three exploration licenses, such as Donje Tlamino and Surlica-Dukat covering an area of 192 square kilometers located in the far southeast of Serbia. The company was incorporated in 1966 and is headquartered in Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MED.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025